FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment

Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the tran...

Full description

Saved in:
Bibliographic Details
Published inMolecular endocrinology (Baltimore, Md.) Vol. 23; no. 2; pp. 213 - 225
Main Authors Ma, Qiuping, Fu, Wei, Li, Pengfei, Nicosia, Santo V., Jenster, Guido, Zhang, Xiaohong, Bai, Wenlong
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.02.2009
The Endocrine Society
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.
AbstractList FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione- S -transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells. The studies establish nuclear FoxO factors as mediators of the inhibition of AR N/C interaction and coactivator recruitment by the PTEN tumor suppressor.
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150-655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.
Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor. Their activity is negatively regulated by AKT-mediated phosphorylation. Our previous studies showed that the transcriptional activity of the androgen receptor (AR) was inhibited by PTEN in an AKT-sensitive manner. Here, we report the repression of the activity of the full-length AR and its N-terminal domain by FoxO1 and the participation of FoxO1 in AR inhibition by PTEN. Ectopic expression of active FoxO1 decreased the transcriptional activity of AR as well as androgen-induced cell proliferation and production of prostate-specific antigen. FoxO1 knock down by RNA interference increased the transcriptional activity of the AR in PTEN-intact cells and relieved its inhibition by ectopic PTEN in PTEN-null cells. Mutational analysis revealed that FoxO1 fragment 150–655, which contains the forkhead box and C-terminal activation domain, was required for AR inhibition. Mammalian two-hybrid and glutathione-S-transferase pull-down assays demonstrated that the inhibition of AR activity by PTEN through FoxO1 involved the interference of androgen-induced interaction of the N- and C-termini of the AR and the recruitment of the p160 coactivators to its N terminus and to the androgen response elements of natural AR target genes. These studies reveal new mechanisms for the inhibition of AR activity by PTEN-FoxO axis and establish FoxO proteins as important nuclear factors that mediate the mutual antagonism between AR and PTEN tumor suppressor in prostate cancer cells.
Author Nicosia, Santo V.
Ma, Qiuping
Jenster, Guido
Bai, Wenlong
Li, Pengfei
Zhang, Xiaohong
Fu, Wei
Author_xml – sequence: 1
  givenname: Qiuping
  surname: Ma
  fullname: Ma, Qiuping
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
– sequence: 2
  givenname: Wei
  surname: Fu
  fullname: Fu, Wei
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
– sequence: 3
  givenname: Pengfei
  surname: Li
  fullname: Li, Pengfei
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
– sequence: 4
  givenname: Santo V.
  surname: Nicosia
  fullname: Nicosia, Santo V.
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
– sequence: 5
  givenname: Guido
  surname: Jenster
  fullname: Jenster, Guido
  organization: 5Department of Urology (G.J.), Josephine Nefkens Institute, Be362a, Erasmus MC, the Netherlands
– sequence: 6
  givenname: Xiaohong
  surname: Zhang
  fullname: Zhang, Xiaohong
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
– sequence: 7
  givenname: Wenlong
  surname: Bai
  fullname: Bai, Wenlong
  email: wbai@health.usf.edu
  organization: 1Departments of Pathology and Cell Biology (Q.M., W.F., P.L., S.V.N., X.Z., W.B.), Tampa, Florida 33612-4799
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19074551$$D View this record in MEDLINE/PubMed
BookMark eNp1ks1vFSEUxYmpsa_VnWvDSjdOBYZhmI1J89Jqk9oafa4JMHcqZgZGYBr972V89TPpipD7O-eQezhCBz54QOgpJSeUUfJqghNGiKwI5e0DtKEd51XX0fYAbYiUspKSdIfoKKUvpCCNpI_QIe1Iy5uGblA4D9-uKX4HvdMZEn6_O7vCH5d5jpCSCx6HAZ_6PoYb8PgDWJhziPiqwtr3eFvtIE7O6xFf-AxR21wkaT8L6-1Wr3jRxcXlCXx-jB4Oekzw5O48Rp_Oz3bbt9Xl9ZuL7ellZTnluTJysNq0VA8Gas4so0b39UAM50LbWtjWdrLnPRUCGrBMdqampjOiA9tzLepj9HrvOy9mgt6W6KhHNUc36fhdBe3UvxPvPqubcKuY4EIwVgye3xnE8HWBlNXkkoVx1B7CkpQQsmlqXhfw2d9JvyN-7bgAL_eAjSGlCMMfhKi1QjWBWitUa4UFZ__h1mW9Lra80433iV7sRWGZ77P_-UPqH-1wrTo
CitedBy_id crossref_primary_10_3390_ijms25105302
crossref_primary_10_1007_s00403_019_01908_x
crossref_primary_10_1111_j_1610_0387_2010_07344_x
crossref_primary_10_1111_j_1365_2133_2010_09754_x
crossref_primary_10_1186_s13046_024_03097_6
crossref_primary_10_1111_exd_12142
crossref_primary_10_1016_j_mce_2013_09_036
crossref_primary_10_1038_emboj_2011_328
crossref_primary_10_1111_j_1365_2133_2010_10033_x
crossref_primary_10_4161_derm_15331
crossref_primary_10_1016_j_eururo_2014_10_027
crossref_primary_10_1177_1534735414534728
crossref_primary_10_1016_j_bone_2011_05_023
crossref_primary_10_4161_derm_19828
crossref_primary_10_1007_s00403_012_1265_x
crossref_primary_10_1111_bjd_14409
crossref_primary_10_3390_biomedicines10081872
crossref_primary_10_1159_000375370
crossref_primary_10_1186_s12986_017_0212_4
crossref_primary_10_1002_pros_21162
crossref_primary_10_1242_dev_044560
crossref_primary_10_1186_s12951_023_01812_7
crossref_primary_10_1002_ijc_27973
crossref_primary_10_1111_exd_14277
crossref_primary_10_1016_j_stemcr_2015_01_018
crossref_primary_10_1111_iep_12460
crossref_primary_10_1111_exd_13787
crossref_primary_10_1530_JOE_10_0480
crossref_primary_10_1158_0008_5472_CAN_09_1504
crossref_primary_10_1016_j_mce_2011_03_026
crossref_primary_10_18632_oncotarget_260
crossref_primary_10_1172_JCI71545
crossref_primary_10_3390_cells10051219
crossref_primary_10_1002_pros_22649
crossref_primary_10_1016_j_exger_2012_03_020
crossref_primary_10_1007_s00018_010_0511_7
crossref_primary_10_1002_pros_22646
crossref_primary_10_1371_journal_pone_0072400
crossref_primary_10_1002_pros_22566
crossref_primary_10_1074_jbc_R109_075044
crossref_primary_10_1016_j_jdsct_2024_100017
Cites_doi 10.1074/jbc.M704735200
10.1210/mend.16.4.0818
10.1074/jbc.M610447200
10.1093/jnci/91.22.1922
10.1093/carcin/18.6.1215
10.1016/S1535-6108(02)00086-7
10.1073/pnas.0437824100
10.1074/jbc.272.47.29821
10.1038/sj.onc.1209086
10.1016/S1097-2765(00)80303-2
10.1038/sj.onc.1203126
10.1210/me.2001-0316
10.1210/mend.13.3.0255
10.1074/jbc.270.13.7341
10.1210/mend-5-10-1396
10.1074/jbc.M104278200
10.1038/ncb1546
10.3322/canjclin.43.1.7
10.1210/jc.2002-021324
10.1074/jbc.M010226200
10.1016/S1097-2765(02)00471-9
10.1677/jme.0.0310169
10.1677/jme.0.0220313
10.1210/me.2004-0065
10.1128/MCB.23.1.104-118.2003
10.1074/jbc.M207509200
10.1074/jbc.270.50.29983
10.1210/me.2004-0190
10.1126/science.1086336
10.1128/MCB.19.9.6164
10.1158/0008-5472.CAN-06-4202
10.1093/genetics/139.4.1567
10.1016/S1535-6108(03)00215-0
10.1515/BC.2005.009
10.1073/pnas.96.5.2110
10.1126/science.1152257
10.1146/annurev.bi.63.070194.002315
10.1002/jcb.10653
10.1016/j.cell.2006.03.046
10.1210/mend.15.6.0647
10.1007/s00018-003-2309-3
10.1128/MCB.19.9.6085
10.1074/jbc.M204131200
10.1074/jbc.M002807200
10.1073/pnas.0602567103
10.1210/en.2003-0568
10.1016/j.cell.2006.12.029
10.1128/MCB.19.2.1182
10.1158/0008-5472.CAN-06-0411
ContentType Journal Article
Copyright Copyright © 2009 by The Endocrine Society 2009
Copyright © 2009 by The Endocrine Society 2009
Copyright_xml – notice: Copyright © 2009 by The Endocrine Society 2009
– notice: Copyright © 2009 by The Endocrine Society 2009
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1210/me.2008-0147
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1944-9917
EndPage 225
ExternalDocumentID PMC2646622
19074551
10_1210_me_2008_0147
10.1210/me.2008-0147
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA93666
– fundername: NCI NIH HHS
  grantid: R01 CA111334
– fundername: NCI NIH HHS
  grantid: R01 CA093666
– fundername: NCI NIH HHS
  grantid: CA111334
GroupedDBID ---
-DZ
.55
.XZ
08P
123
18M
29M
2WC
34G
354
39C
3O-
4.4
53G
5RS
5YH
8F7
AABZA
AACZT
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
ABJNI
ABNHQ
ABOCM
ABPPZ
ABPTD
ABXVV
ACGFO
ACGFS
ACUFI
ADBBV
ADGZP
ADIYS
ADQBN
ADVEK
AENEX
AETEA
AFFNX
AFFZL
AFOFC
AFOSN
AFXAL
AGINJ
AGUTN
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ATGXG
BAWUL
BAYMD
BCRHZ
C45
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FLUFQ
FOEOM
GX1
H13
HF~
HZ~
H~9
IH2
KQ8
KSI
KSN
L7B
M5~
NOMLY
OAUYM
OBH
OFXIZ
OHH
OJZSN
OK1
OPAEJ
OVD
P2P
REU
ROX
ROZ
TEORI
TJX
TR2
VVN
W8F
WOQ
X7M
XOL
YBU
YOC
ZCA
ZY1
0R~
AAFWJ
AAYXX
ABDFA
ABEJV
ABGNP
ABVGC
ADVOB
AEMQT
AHMMS
ALXQX
CITATION
.GJ
AAKAS
ACFRR
ACUTJ
ACVCV
ADZCM
AGMDO
APJGH
AQKUS
ASAOO
ATDFG
CGR
CUY
CVF
ECM
EIF
MBLQV
MBTAY
NPM
WHG
X52
ZCG
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c414t-b8fcab71afbe342c21bad3f0b446ac36c7c98d4d166e5ec289b31b9b69ecd4a63
ISSN 0888-8809
IngestDate Thu Aug 21 14:07:54 EDT 2025
Thu Jul 10 17:23:14 EDT 2025
Thu Apr 03 07:03:42 EDT 2025
Tue Jul 01 01:47:42 EDT 2025
Thu Apr 24 23:03:48 EDT 2025
Wed Sep 11 05:00:55 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c414t-b8fcab71afbe342c21bad3f0b446ac36c7c98d4d166e5ec289b31b9b69ecd4a63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Address all correspondence and requests for reprints to: Wenlong Bai, Ph.D., Departments of Pathology and Cell Biology, University of South Florida, College of Medicine, 12901 Bruce B. Downs Boulevard, MDC 11, Tampa, Florida 33612-4799. E-mail: wbai@health.usf.edu.
OpenAccessLink https://academic.oup.com/mend/article-pdf/23/2/213/8941908/mend0213.pdf
PMID 19074551
PQID 66855343
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2646622
proquest_miscellaneous_66855343
pubmed_primary_19074551
crossref_primary_10_1210_me_2008_0147
crossref_citationtrail_10_1210_me_2008_0147
oup_primary_10_1210_me_2008-0147
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-02-01
PublicationDateYYYYMMDD 2009-02-01
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Molecular endocrinology (Baltimore, Md.)
PublicationTitleAlternate Mol Endocrinol
PublicationYear 2009
Publisher Oxford University Press
The Endocrine Society
Publisher_xml – name: Oxford University Press
– name: The Endocrine Society
References Fan (2019041200062926400_R24) 2007; 282
Hsu (2019041200062926400_R29) 2005; 19
Jiao (2019041200062926400_R40) 2007; 67
Li (2019041200062926400_R12) 2001; 276
Jenster (2019041200062926400_R44) 1995; 270
Boring (2019041200062926400_R1) 1993; 43
Shen (2019041200062926400_R28) 2005; 386
He (2019041200062926400_R4) 2000; 275
Paik (2019041200062926400_R41) 2007; 128
Nawaz (2019041200062926400_R42) 1999; 19
Louie (2019041200062926400_R47) 2003; 100
Langley (2019041200062926400_R5) 1995; 270
Gioeli (2019041200062926400_R36) 2002; 277
Kasper (2019041200062926400_R19) 1999; 22
Chang (2019041200062926400_R30) 2002; 16
Zhao (2019041200062926400_R18) 2001; 276
Larsen (2019041200062926400_R32) 1995; 139
Modur (2019041200062926400_R49) 2002; 277
Ma (2019041200062926400_R21) 1999; 19
Jenster (2019041200062926400_R3) 1991; 5
Dong (2019041200062926400_R23) 2006; 66
Ali (2019041200062926400_R9) 1999; 91
Dutertre (2019041200062926400_R45) 2003; 17
Ramaswamy (2019041200062926400_R20) 2002; 2
Reddy (2019041200062926400_R11) 2008; 319
Thompson (2019041200062926400_R26) 2001; 15
Nan (2019041200062926400_R35) 2003; 31
Lehtinen (2019041200062926400_R14) 2006; 125
Castrillon (2019041200062926400_R34) 2003; 301
Xin (2019041200062926400_R37) 2006; 103
Zhang (2019041200062926400_R17) 2004; 145
Wang (2019041200062926400_R39) 2003; 4
Bello (2019041200062926400_R16) 1997; 18
Hatta (2019041200062926400_R25) 2007; 282
Lee (2019041200062926400_R7) 2003; 60
Stambolic (2019041200062926400_R8) 1999; 18
Shang (2019041200062926400_R46) 2002; 9
Wissmann (2019041200062926400_R48) 2007; 9
Ikonen (2019041200062926400_R6) 1997; 272
Kemppainen (2019041200062926400_R31) 1999; 13
Powzaniuk (2019041200062926400_R43) 2004; 18
Greer (2019041200062926400_R10) 2005; 24
Li (2019041200062926400_R13) 2003; 23
Tsai (2019041200062926400_R2) 1994; 63
Ramaswamy (2019041200062926400_R15) 1999; 96
Taplin (2019041200062926400_R38) 2004; 91
Alen (2019041200062926400_R22) 1999; 19
Ghali (2019041200062926400_R27) 2003; 88
Ogg (2019041200062926400_R33) 1998; 2
10557100 - Oncogene. 1999 Nov 1;18(45):6094-103
8422609 - CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26
18239123 - Science. 2008 Feb 1;319(5863):611-3
10454563 - Mol Cell Biol. 1999 Sep;19(9):6164-73
12855809 - Science. 2003 Jul 11;301(5630):215-8
12727974 - J Clin Endocrinol Metab. 2003 May;88(5):2185-93
14522255 - Cancer Cell. 2003 Sep;4(3):209-21
14500578 - Endocrinology. 2004 Jan;145(1):134-48
17616663 - Cancer Res. 2007 Jul 1;67(13):6083-91
12150827 - Cancer Cell. 2002 Jul;2(1):81-91
17202144 - J Biol Chem. 2007 Mar 9;282(10):7329-38
16751106 - Cell. 2006 Jun 2;125(5):987-1001
17923482 - J Biol Chem. 2007 Dec 7;282(49):35583-93
10051603 - Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2110-5
10816582 - J Biol Chem. 2000 Jul 28;275(30):22986-94
12015328 - J Biol Chem. 2002 Aug 9;277(32):29304-14
9214605 - Carcinogenesis. 1997 Jun;18(6):1215-23
9368054 - J Biol Chem. 1997 Nov 21;272(47):29821-8
10454556 - Mol Cell Biol. 1999 Sep;19(9):6085-97
17254969 - Cell. 2007 Jan 26;128(2):309-23
12589022 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2226-30
12351634 - J Biol Chem. 2002 Dec 6;277(49):47928-37
10564676 - J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32
7706276 - J Biol Chem. 1995 Mar 31;270(13):7341-6
15514032 - Mol Endocrinol. 2005 Feb;19(2):350-61
10343290 - J Mol Endocrinol. 1999 Jun;22(3):313-25
10077001 - Mol Endocrinol. 1999 Mar;13(3):440-54
7789761 - Genetics. 1995 Apr;139(4):1567-83
12714702 - Mol Endocrinol. 2003 Jul;17(7):1296-314
11353774 - J Biol Chem. 2001 Jul 27;276(30):27907-12
16849544 - Cancer Res. 2006 Jul 15;66(14):6998-7006
12482965 - Mol Cell Biol. 2003 Jan;23(1):104-18
7979245 - Annu Rev Biochem. 1994;63:451-86
14504652 - Cell Mol Life Sci. 2003 Aug;60(8):1613-22
9885576 - Mol Cell. 1998 Dec;2(6):887-93
16682621 - Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94
15843149 - Biol Chem. 2005 Jan;386(1):69-74
12914534 - J Mol Endocrinol. 2003 Aug;31(1):169-83
8530400 - J Biol Chem. 1995 Dec 15;270(50):29983-90
11278645 - J Biol Chem. 2001 Jun 8;276(23):20444-50
11923463 - Mol Endocrinol. 2002 Apr;16(4):647-60
9891052 - Mol Cell Biol. 1999 Feb;19(2):1182-9
11376111 - Mol Endocrinol. 2001 Jun;15(6):923-35
11931767 - Mol Cell. 2002 Mar;9(3):601-10
15131260 - Mol Endocrinol. 2004 Aug;18(8):2011-23
17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53
14755679 - J Cell Biochem. 2004 Feb 15;91(3):483-90
16288288 - Oncogene. 2005 Nov 14;24(50):7410-25
1775129 - Mol Endocrinol. 1991 Oct;5(10):1396-404
References_xml – volume: 282
  start-page: 35583
  year: 2007
  ident: 2019041200062926400_R25
  article-title: Chromatin opening and stable perturbation of core histone:DNA contacts by FoxO1.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M704735200
– volume: 16
  start-page: 647
  year: 2002
  ident: 2019041200062926400_R30
  article-title: Evaluation of ligand-dependent changes in AR structure using peptide probes.
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.16.4.0818
– volume: 282
  start-page: 7329
  year: 2007
  ident: 2019041200062926400_R24
  article-title: Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M610447200
– volume: 91
  start-page: 1922
  year: 1999
  ident: 2019041200062926400_R9
  article-title: Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity.
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/91.22.1922
– volume: 18
  start-page: 1215
  year: 1997
  ident: 2019041200062926400_R16
  article-title: Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/18.6.1215
– volume: 2
  start-page: 81
  year: 2002
  ident: 2019041200062926400_R20
  article-title: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR.
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(02)00086-7
– volume: 100
  start-page: 2226
  year: 2003
  ident: 2019041200062926400_R47
  article-title: Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex.
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0437824100
– volume: 272
  start-page: 29821
  year: 1997
  ident: 2019041200062926400_R6
  article-title: Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.272.47.29821
– volume: 24
  start-page: 7410
  year: 2005
  ident: 2019041200062926400_R10
  article-title: FOXO transcription factors at the interface between longevity and tumor suppression.
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209086
– volume: 2
  start-page: 887
  year: 1998
  ident: 2019041200062926400_R33
  article-title: The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway.
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(00)80303-2
– volume: 18
  start-page: 6094
  year: 1999
  ident: 2019041200062926400_R8
  article-title: Modulation of cellular apoptotic potential: contributions to oncogenesis.
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203126
– volume: 17
  start-page: 1296
  year: 2003
  ident: 2019041200062926400_R45
  article-title: Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-α: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2001-0316
– volume: 13
  start-page: 440
  year: 1999
  ident: 2019041200062926400_R31
  article-title: Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.13.3.0255
– volume: 270
  start-page: 7341
  year: 1995
  ident: 2019041200062926400_R44
  article-title: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.13.7341
– volume: 5
  start-page: 1396
  year: 1991
  ident: 2019041200062926400_R3
  article-title: Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization.
  publication-title: Mol Endocrinol
  doi: 10.1210/mend-5-10-1396
– volume: 276
  start-page: 27907
  year: 2001
  ident: 2019041200062926400_R18
  article-title: Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M104278200
– volume: 9
  start-page: 347
  year: 2007
  ident: 2019041200062926400_R48
  article-title: Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor- dependent gene expression.
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1546
– volume: 43
  start-page: 7
  year: 1993
  ident: 2019041200062926400_R1
  article-title: Cancer statistics, 1993.
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.43.1.7
– volume: 88
  start-page: 2185
  year: 2003
  ident: 2019041200062926400_R27
  article-title: The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2002-021324
– volume: 276
  start-page: 20444
  year: 2001
  ident: 2019041200062926400_R12
  article-title: Antagonism between PTEN/MMAC1/TEP-1 and androgen receptor in growth and apoptosis of prostatic cancer cells.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M010226200
– volume: 9
  start-page: 601
  year: 2002
  ident: 2019041200062926400_R46
  article-title: Formation of the androgen receptor transcription complex.
  publication-title: Mol Cell
  doi: 10.1016/S1097-2765(02)00471-9
– volume: 31
  start-page: 169
  year: 2003
  ident: 2019041200062926400_R35
  article-title: The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity.
  publication-title: J Mol Endocrinol
  doi: 10.1677/jme.0.0310169
– volume: 22
  start-page: 313
  year: 1999
  ident: 2019041200062926400_R19
  article-title: Selective activation of the probasin androgen-responsive region by steroid hormones.
  publication-title: J Mol Endocrinol
  doi: 10.1677/jme.0.0220313
– volume: 18
  start-page: 2011
  year: 2004
  ident: 2019041200062926400_R43
  article-title: The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor.
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2004-0065
– volume: 23
  start-page: 104
  year: 2003
  ident: 2019041200062926400_R13
  article-title: AKT-independent protection of prostate cancer cells from apoptosis mediated through complex formation between the androgen receptor and FKHR.
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.23.1.104-118.2003
– volume: 277
  start-page: 47928
  year: 2002
  ident: 2019041200062926400_R49
  article-title: FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M207509200
– volume: 270
  start-page: 29983
  year: 1995
  ident: 2019041200062926400_R5
  article-title: Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.270.50.29983
– volume: 19
  start-page: 350
  year: 2005
  ident: 2019041200062926400_R29
  article-title: Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth.
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2004-0190
– volume: 301
  start-page: 215
  year: 2003
  ident: 2019041200062926400_R34
  article-title: Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a.
  publication-title: Science
  doi: 10.1126/science.1086336
– volume: 19
  start-page: 6164
  year: 1999
  ident: 2019041200062926400_R21
  article-title: Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins.
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.9.6164
– volume: 67
  start-page: 6083
  year: 2007
  ident: 2019041200062926400_R40
  article-title: Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-4202
– volume: 139
  start-page: 1567
  year: 1995
  ident: 2019041200062926400_R32
  article-title: Genes that regulate both development and longevity in Caenorhabditis elegans.
  publication-title: Genetics
  doi: 10.1093/genetics/139.4.1567
– volume: 4
  start-page: 209
  year: 2003
  ident: 2019041200062926400_R39
  article-title: Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
  publication-title: Cancer Cell
  doi: 10.1016/S1535-6108(03)00215-0
– volume: 386
  start-page: 69
  year: 2005
  ident: 2019041200062926400_R28
  article-title: GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
  publication-title: Biol Chem
  doi: 10.1515/BC.2005.009
– volume: 96
  start-page: 2110
  year: 1999
  ident: 2019041200062926400_R15
  article-title: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.96.5.2110
– volume: 319
  start-page: 611
  year: 2008
  ident: 2019041200062926400_R11
  article-title: Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool.
  publication-title: Science
  doi: 10.1126/science.1152257
– volume: 63
  start-page: 451
  year: 1994
  ident: 2019041200062926400_R2
  article-title: Molecular mechanisms of action of steroid/thyroid receptor superfamily members.
  publication-title: Annu Rev Biochem
  doi: 10.1146/annurev.bi.63.070194.002315
– volume: 91
  start-page: 483
  year: 2004
  ident: 2019041200062926400_R38
  article-title: Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.10653
– volume: 125
  start-page: 987
  year: 2006
  ident: 2019041200062926400_R14
  article-title: A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span.
  publication-title: Cell
  doi: 10.1016/j.cell.2006.03.046
– volume: 15
  start-page: 923
  year: 2001
  ident: 2019041200062926400_R26
  article-title: Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
  publication-title: Mol Endocrinol
  doi: 10.1210/mend.15.6.0647
– volume: 60
  start-page: 1613
  year: 2003
  ident: 2019041200062926400_R7
  article-title: Recent advances in androgen receptor action.
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-003-2309-3
– volume: 19
  start-page: 6085
  year: 1999
  ident: 2019041200062926400_R22
  article-title: The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.9.6085
– volume: 277
  start-page: 29304
  year: 2002
  ident: 2019041200062926400_R36
  article-title: Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M204131200
– volume: 275
  start-page: 22986
  year: 2000
  ident: 2019041200062926400_R4
  article-title: FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M002807200
– volume: 103
  start-page: 7789
  year: 2006
  ident: 2019041200062926400_R37
  article-title: Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor.
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0602567103
– volume: 145
  start-page: 134
  year: 2004
  ident: 2019041200062926400_R17
  article-title: An androgen-dependent upstream enhancer is essential for high levels of probasin gene expression.
  publication-title: Endocrinology
  doi: 10.1210/en.2003-0568
– volume: 128
  start-page: 309
  year: 2007
  ident: 2019041200062926400_R41
  article-title: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.
  publication-title: Cell
  doi: 10.1016/j.cell.2006.12.029
– volume: 19
  start-page: 1182
  year: 1999
  ident: 2019041200062926400_R42
  article-title: The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily.
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.2.1182
– volume: 66
  start-page: 6998
  year: 2006
  ident: 2019041200062926400_R23
  article-title: FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer.
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-0411
– reference: 7789761 - Genetics. 1995 Apr;139(4):1567-83
– reference: 10454556 - Mol Cell Biol. 1999 Sep;19(9):6085-97
– reference: 15514032 - Mol Endocrinol. 2005 Feb;19(2):350-61
– reference: 12727974 - J Clin Endocrinol Metab. 2003 May;88(5):2185-93
– reference: 17277772 - Nat Cell Biol. 2007 Mar;9(3):347-53
– reference: 10564676 - J Natl Cancer Inst. 1999 Nov 17;91(22):1922-32
– reference: 16288288 - Oncogene. 2005 Nov 14;24(50):7410-25
– reference: 17202144 - J Biol Chem. 2007 Mar 9;282(10):7329-38
– reference: 11278645 - J Biol Chem. 2001 Jun 8;276(23):20444-50
– reference: 10343290 - J Mol Endocrinol. 1999 Jun;22(3):313-25
– reference: 17616663 - Cancer Res. 2007 Jul 1;67(13):6083-91
– reference: 9214605 - Carcinogenesis. 1997 Jun;18(6):1215-23
– reference: 12914534 - J Mol Endocrinol. 2003 Aug;31(1):169-83
– reference: 12351634 - J Biol Chem. 2002 Dec 6;277(49):47928-37
– reference: 16849544 - Cancer Res. 2006 Jul 15;66(14):6998-7006
– reference: 9885576 - Mol Cell. 1998 Dec;2(6):887-93
– reference: 14504652 - Cell Mol Life Sci. 2003 Aug;60(8):1613-22
– reference: 7979245 - Annu Rev Biochem. 1994;63:451-86
– reference: 10557100 - Oncogene. 1999 Nov 1;18(45):6094-103
– reference: 7706276 - J Biol Chem. 1995 Mar 31;270(13):7341-6
– reference: 16682621 - Proc Natl Acad Sci U S A. 2006 May 16;103(20):7789-94
– reference: 10051603 - Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2110-5
– reference: 8422609 - CA Cancer J Clin. 1993 Jan-Feb;43(1):7-26
– reference: 17923482 - J Biol Chem. 2007 Dec 7;282(49):35583-93
– reference: 12589022 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2226-30
– reference: 10077001 - Mol Endocrinol. 1999 Mar;13(3):440-54
– reference: 12482965 - Mol Cell Biol. 2003 Jan;23(1):104-18
– reference: 15131260 - Mol Endocrinol. 2004 Aug;18(8):2011-23
– reference: 12714702 - Mol Endocrinol. 2003 Jul;17(7):1296-314
– reference: 1775129 - Mol Endocrinol. 1991 Oct;5(10):1396-404
– reference: 17254969 - Cell. 2007 Jan 26;128(2):309-23
– reference: 12015328 - J Biol Chem. 2002 Aug 9;277(32):29304-14
– reference: 14522255 - Cancer Cell. 2003 Sep;4(3):209-21
– reference: 14500578 - Endocrinology. 2004 Jan;145(1):134-48
– reference: 11931767 - Mol Cell. 2002 Mar;9(3):601-10
– reference: 12855809 - Science. 2003 Jul 11;301(5630):215-8
– reference: 14755679 - J Cell Biochem. 2004 Feb 15;91(3):483-90
– reference: 9891052 - Mol Cell Biol. 1999 Feb;19(2):1182-9
– reference: 11376111 - Mol Endocrinol. 2001 Jun;15(6):923-35
– reference: 8530400 - J Biol Chem. 1995 Dec 15;270(50):29983-90
– reference: 15843149 - Biol Chem. 2005 Jan;386(1):69-74
– reference: 18239123 - Science. 2008 Feb 1;319(5863):611-3
– reference: 10454563 - Mol Cell Biol. 1999 Sep;19(9):6164-73
– reference: 16751106 - Cell. 2006 Jun 2;125(5):987-1001
– reference: 11923463 - Mol Endocrinol. 2002 Apr;16(4):647-60
– reference: 12150827 - Cancer Cell. 2002 Jul;2(1):81-91
– reference: 11353774 - J Biol Chem. 2001 Jul 27;276(30):27907-12
– reference: 9368054 - J Biol Chem. 1997 Nov 21;272(47):29821-8
– reference: 10816582 - J Biol Chem. 2000 Jul 28;275(30):22986-94
SSID ssj0014581
Score 2.188097
Snippet Abstract FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on...
FoxO (mammalian forkhead subclass O) proteins are transcription factors acting downstream of the PTEN (phosphatase and tensin homolog deleted on chromosome 10)...
SourceID pubmedcentral
proquest
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 213
SubjectTerms Animals
Cell Line
Forkhead Transcription Factors - genetics
Forkhead Transcription Factors - metabolism
Gene Expression Regulation
Humans
Protein Isoforms - genetics
Protein Isoforms - metabolism
Protein Structure, Tertiary
PTEN Phosphohydrolase - genetics
PTEN Phosphohydrolase - metabolism
Receptors, Androgen - chemistry
Receptors, Androgen - genetics
Receptors, Androgen - metabolism
RNA Interference
src-Family Kinases - genetics
src-Family Kinases - metabolism
Transcription, Genetic
Title FoxO1 Mediates PTEN Suppression of Androgen Receptor N- and C-Terminal Interactions and Coactivator Recruitment
URI https://www.ncbi.nlm.nih.gov/pubmed/19074551
https://www.proquest.com/docview/66855343
https://pubmed.ncbi.nlm.nih.gov/PMC2646622
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSIgXBBuXcvUD8FJ5WmLXSR7H1GlCaweilfoW2Y4zIrVp1SZI8Os5viRN0CYuL1HruE7V7-vJOc53zkHoXZjFWa51REIWU8J0IImgUhElIxVQbSqGWbXFlF_M2afFaLGX29rskkoeq5835pX8D6owBriaLNl_QLZdFAbgNeALR0AYjn-FMdw6rgKX_GG2Tz_PxtPhrt54bat1BIUpSAALDMGy6Q0E2MMpsQ8MzojXwSxtyYitS3DY-Tw38-67icfN57Z1UbUCmab7U9NWd6jLbA2mx-3PG4f1o1hWRaPfnWTHnc2GiXVVvxT1prljGurUVuini1YcVDjlcHmd7wcNZXdO2fvVND726txmwyJpNM4duxYTMBtJ1wi7pGNPtrBnUemNlh5CVYBnZSudGjmeq9vZL6g9vUrP55eX6Wy8mN1F90KIJGw--KJVAQVsZPvYtt_J50aYxKbu2j2vpZcJ2QlIftfVdhyV2SP00EcY-NTR5TG6o8tDdHRaApqrH_gDtppfC9Yhuj_x0oojtLZkwg2ZsCET7pAJr3PckAk3ZMJTYgbxnky4SyZ7rkMm3CHTEzQ_H8_OLojvxkEUC1hFZJwrIaNA5FJTFqowkCKj-YlkjAtFuYpUEmcsCzjXI60gkJc0kInkiVYZE5w-RQflutTPEQa3XwimpBaCMnaSx3kgZZQorsB9zFU2QMPm106VL1VvOqYsUxOyAjbpSvv-qYDNAL1vZ29ciZZb5mEA7rYpxE1526Cagpk1z85Eqdf1LuU8Ho0oowP0zGG8X8dsL0HcMUBRD_12ging3j9TFt9sIXcIRjgPwxd_vOpL9GD_T3qFDqptrV-DM1zJN5bOvwAR0Lm8
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FoxO1+mediates+PTEN+suppression+of+androgen+receptor+N-+and+C-terminal+interactions+and+coactivator+recruitment&rft.jtitle=Molecular+endocrinology+%28Baltimore%2C+Md.%29&rft.au=Ma%2C+Qiuping&rft.au=Fu%2C+Wei&rft.au=Li%2C+Pengfei&rft.au=Nicosia%2C+Santo+V&rft.date=2009-02-01&rft.issn=0888-8809&rft.volume=23&rft.issue=2&rft.spage=213&rft_id=info:doi/10.1210%2Fme.2008-0147&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0888-8809&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0888-8809&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0888-8809&client=summon